Communication

Actualités

AGS Therapeutics Strengthens its Patent portfolio on Microalgae Extracellular Vesicles (MEV) with an International Patent

22 janvier 2024
Actualités

MEVs are a universal delivery system; suitable for delivering innovative therapeutics, vaccines and gene therapies. MEVs can be administered through multiple routes; they overcome stringent biological barriers and reach difficult-to-access tissues, providing the potential to overcome challenges faced by other delivery systems. MEVs deliver their payload in target tissues of interest, where the payload elicits its desired biological activity. MEVs can be exo-loaded or endo-loaded with a diversity of payloads or therapeutic modalities. To know more